New compound that slows down the onset and progression of Parkinson’s disease in mice
Research groups led by Armin Giese of LMU Munich and Christian Griesinger at the Max Planck Institute for Biophysical Chemistry in Göttingen have developed a chemical compound that slows down the onset and progression of Parkinson’s disease in mice. As a consequence, mice treated with this agent remain disease-free for longer than non-medicated controls.
More information at the link below: